Loading
IARC estimates 70,520 new cancer cases and 51,108 cancer deaths in Democratic People's Republic of Korea in 2024; the commonest new cancers are trachea, bronchus and lung, liver and intrahepatic bile ducts and stomach. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
Built partly from other countries' data. IARC's method code for Democratic People's Republic of Korea's incidence estimate is 5: rates based on incidence estimates or registry data from neighbouring countries. Read the figures as a regional estimate, not a count.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Trachea, bronchus and lung | 16,904 | 38.4 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Liver and intrahepatic bile ducts | 8,912 | 21.1 | Hepatocellular carcinoma |
| Stomach | 7,061 | 16.2 | Gastric & gastro-oesophageal junction cancer |
| Colorectum | 6,947 | 15.9 | Colorectal cancer |
| Breast | 5,123 | 27.1 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Thyroid | 4,114 | 12.4 | Thyroid cancer |
| Pancreas | 2,126 | 4.7 | Pancreatic ductal adenocarcinoma |
| Cervix uteri | 2,106 | 11.0 | Cervical cancer |
| Bladder | 2,079 | 4.7 | Bladder & urothelial cancer |
| Oesophagus | 1,883 | 4.3 | Oesophageal cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Trachea, bronchus and lung | 14,650 | 33.3 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Liver and intrahepatic bile ducts | 8,432 | 19.8 | Hepatocellular carcinoma |
| Stomach | 6,176 | 13.9 | Gastric & gastro-oesophageal junction cancer |
| Colorectum | 3,806 | 8.6 | Colorectal cancer |
| Breast | 2,388 | 12.3 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Pancreas | 2,072 | 4.6 | Pancreatic ductal adenocarcinoma |
| Oesophagus | 1,774 | 4.1 | Oesophageal cancer |
| Brain, central nervous system | 1,336 | 3.5 | Glioma & glioblastoma |
| Bladder | 1,309 | 2.9 | Bladder & urothelial cancer |
| Cervix uteri | 1,281 | 6.6 | Cervical cancer |
No trial record in OnCo lists a site in Democratic People's Republic of Korea. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Democratic People's Republic of Korea.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Democratic People's Republic of Korea is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
A deep dive for Democratic People's Republic of Korea is ranked 55 of 60 in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.